Europe Gene Synthesis Market By Method (Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis), By Service Type (Antibody DNA Synthesis, Viral DNA Synthesis and Others), By Application (Gene & Cell Therapy Development, Vaccine Develop
Description
Europe Gene Synthesis Market By Method (Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis), By Service Type (Antibody DNA Synthesis, Viral DNA Synthesis and Others), By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others), By End User (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
The Europe Gene Synthesis Market would witness market growth of 17.4% CAGR during the forecast period (2021-2027).
The purpose of gene synthesis is to chemically synthesize the DNA oligonucleotides and their assembly into circuits, synthons, genes, and complete genomes and build, design, test, learn, and repeat the cycle underpinning the innovations in synthetic biology.
Sequencing, amplification, and automation are now the essential parts of the clinical research procedures centered on life science domains like cancer biology, genetics, neuroscience, antibody engineering, and biochemistry. These factors are consecutively increasing the growth and development related to the gene synthesis sciences.
As stated in a report of the European parliament, synthetic biology is considered as one of the continuously developing technologies. The increase in the funding and investments by pharmaceutical and biotech organizations with the purpose to enhance the quality and quantity of researches and developments in the field of synthetic biology would also be a major factor for the development of the gene synthesis processes across the region.
The Germany market dominated the Europe Gene Synthesis Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $362 million by 2027. The UK market would witness a CAGR of 16.6% during (2021 - 2027). Additionally, The France market is poised to grow a CAGR of 18.3% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
Scope of the Study
Market Segments covered in the Report:
By Method
The Europe Gene Synthesis Market would witness market growth of 17.4% CAGR during the forecast period (2021-2027).
The purpose of gene synthesis is to chemically synthesize the DNA oligonucleotides and their assembly into circuits, synthons, genes, and complete genomes and build, design, test, learn, and repeat the cycle underpinning the innovations in synthetic biology.
Sequencing, amplification, and automation are now the essential parts of the clinical research procedures centered on life science domains like cancer biology, genetics, neuroscience, antibody engineering, and biochemistry. These factors are consecutively increasing the growth and development related to the gene synthesis sciences.
As stated in a report of the European parliament, synthetic biology is considered as one of the continuously developing technologies. The increase in the funding and investments by pharmaceutical and biotech organizations with the purpose to enhance the quality and quantity of researches and developments in the field of synthetic biology would also be a major factor for the development of the gene synthesis processes across the region.
The Germany market dominated the Europe Gene Synthesis Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $362 million by 2027. The UK market would witness a CAGR of 16.6% during (2021 - 2027). Additionally, The France market is poised to grow a CAGR of 18.3% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
Scope of the Study
Market Segments covered in the Report:
By Method
- Solid-phase Synthesis
- Chip-based Synthesis and
- PCR-based Enzyme Synthesis
- Antibody DNA Synthesis
- Viral DNA Synthesis and
- Others
- Gene & Cell Therapy Development
- Vaccine Development
- Disease Diagnosis and
- Others
- Academic & Government Research Institutes
- Biotechnology & Pharmaceutical Companies and
- Contract Research Organizations
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Genscript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- Brooks Automation, Inc.
- Boster Biological Technology
- Twist Bioscience Corporation
- Danaher Corporation
- Biomatik Corporation
- ProteoGenix
- ProMab Biotechnologies, Inc.
- OriGene Technologies, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
111 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Gene Synthesis Market, by Method
- 1.4.2 Europe Gene Synthesis Market, by Service Type
- 1.4.3 Europe Gene Synthesis Market, by Application
- 1.4.4 Europe Gene Synthesis Market, by End User
- 1.4.5 Europe Gene Synthesis Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition and scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Acquisition and Mergers
- 3.2.2 Partnerships, Collaborations and Agreements
- 3.2.3 Product Launches and Product Expansions
- 3.2.4 Geographical Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
- 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Dec – 2021, Nov) Leading Players
- 3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2017, Jul – 2021, Aug) Leading Players
- Chapter 4. Europe Gene Synthesis Market by Method
- 4.1 Europe Solid-phase Synthesis Market by Country
- 4.2 Europe Chip-based Synthesis Market by Country
- 4.3 Europe PCR-based Enzyme Synthesis Market by Country
- Chapter 5. Europe Gene Synthesis Market by Service Type
- 5.1 Europe Antibody DNA Synthesis Market by Country
- 5.2 Europe Viral DNA Synthesis Market by Country
- 5.3 Europe Others Market by Country
- Chapter 6. Europe Gene Synthesis Market by Application
- 6.1 Europe Gene & Cell Therapy Development Market by Country
- 6.2 Europe Vaccine Development Market by Country
- 6.3 Europe Disease Diagnosis Market by Country
- 6.4 Europe Others Market by Country
- Chapter 7. Europe Gene Synthesis Market by End User
- 7.1 Europe Academic & Government Research Institutes Market by Country
- 7.2 Europe Biotechnology & Pharmaceutical Companies Market by Country
- 7.3 Europe Contract Research Organizations Market by Country
- Chapter 8. Europe Gene Synthesis Market by Country
- 8.1 Germany Gene Synthesis Market
- 8.1.1 Germany Gene Synthesis Market by Method
- 8.1.2 Germany Gene Synthesis Market by Service Type
- 8.1.3 Germany Gene Synthesis Market by Application
- 8.1.4 Germany Gene Synthesis Market by End User
- 8.2 UK Gene Synthesis Market
- 8.2.1 UK Gene Synthesis Market by Method
- 8.2.2 UK Gene Synthesis Market by Service Type
- 8.2.3 UK Gene Synthesis Market by Application
- 8.2.4 UK Gene Synthesis Market by End User
- 8.3 France Gene Synthesis Market
- 8.3.1 France Gene Synthesis Market by Method
- 8.3.2 France Gene Synthesis Market by Service Type
- 8.3.3 France Gene Synthesis Market by Application
- 8.3.4 France Gene Synthesis Market by End User
- 8.4 Russia Gene Synthesis Market
- 8.4.1 Russia Gene Synthesis Market by Method
- 8.4.2 Russia Gene Synthesis Market by Service Type
- 8.4.3 Russia Gene Synthesis Market by Application
- 8.4.4 Russia Gene Synthesis Market by End User
- 8.5 Spain Gene Synthesis Market
- 8.5.1 Spain Gene Synthesis Market by Method
- 8.5.2 Spain Gene Synthesis Market by Service Type
- 8.5.3 Spain Gene Synthesis Market by Application
- 8.5.4 Spain Gene Synthesis Market by End User
- 8.6 Italy Gene Synthesis Market
- 8.6.1 Italy Gene Synthesis Market by Method
- 8.6.2 Italy Gene Synthesis Market by Service Type
- 8.6.3 Italy Gene Synthesis Market by Application
- 8.6.4 Italy Gene Synthesis Market by End User
- 8.7 Rest of Europe Gene Synthesis Market
- 8.7.1 Rest of Europe Gene Synthesis Market by Method
- 8.7.2 Rest of Europe Gene Synthesis Market by Service Type
- 8.7.3 Rest of Europe Gene Synthesis Market by Application
- 8.7.4 Rest of Europe Gene Synthesis Market by End User
- Chapter 9. Company Profiles
- 9.1 Genscript Biotech Corporation
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional & Segmental Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Product Launches and Product Expansions:
- 9.1.5.3 Acquisition and Mergers:
- 9.1.5.4 Geographical Expansions:
- 9.2 Thermo Fisher Scientific, Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Acquisition and Mergers:
- 9.2.5.3 Geographical Expansions:
- 9.2.6 SWOT Analysis
- 9.3 Brooks Automation, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional & Segmental Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Acquisition and Mergers:
- 9.4 Boster Biological Technology
- 9.4.1 Company Overview
- 9.5 Twist Bioscience Corporation
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional & Segmental Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Acquisition and Mergers:
- 9.5.5.3 Product Launches and Product Expansions:
- 9.5.5.4 Geographical Expansions:
- 9.6 Danaher Corporation
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Product Launches and Product Expansions:
- 9.6.5.2 Acquisition and Mergers:
- 9.6.5.3 Geographical Expansions:
- 9.7 Biomatik Corporation
- 9.7.1 Company Overview
- 9.8 ProteoGenix
- 9.8.1 Company Overview
- 9.9 ProMab Biotechnologies, Inc.
- 9.9.1 Company Overview
- 9.10. OriGene Technologies, Inc.
- 9.10.1 Company Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
